INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
INVO Fertility (Nasdaq: IVF) will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit on Thursday, January 15, 2026.
Rhea-AI Summary
INVO Fertility (Nasdaq: IVF) will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit on Thursday, January 15, 2026. The live webcast begins at 3:00 p.m. ET and will be available at the conference page https://lythampartners.com/hc2026/ivf. A replay will be accessible at the same link after the event. The company focuses on establishing, acquiring, and operating fertility clinics and related technologies.
Positive
- None.
Negative
- None.
Details
News Market Reaction – IVF
On Jan 14, the first trading day after this news, IVF closed 1.01% above the previous close.
Data tracked by StockTitan Argus for the Jan 14 session.
Key Figures
- Conference date
- January 15, 2026
- Lytham Partners 2026 Investor Healthcare Summit webcast date
- Webcast time
- 3:00 p.m. ET
- Scheduled start time for IVF webcast fireside chat
Historical Context
-
Executive shifts to support clinic acquisition-focused growth strategy.
-
Definitive deal to acquire Indiana fertility clinic Family Beginnings.
-
At-the-market private placement with shares and warrants for $4.0M.
-
Initial announcement of intent to acquire Family Beginnings clinic.
-
Announcement of 1-for-8 reverse stock split effective Nov 28, 2025.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit, taking place virtually on Thursday, January 15, 2026.
The webcast will take place at 3:00 p.m. ET on Thursday, January 15, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/hc2026/ or directly at https://lythampartners.com/hc2026/ivf. A replay will also be available through the same links.
About INVO Fertility
We are a healthcare services fertility company dedicated to expanding access to assisted reproductive technology (“ART”) care to patients in need. Our principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including “INVO Centers” dedicated primarily to offering the intravaginal culture (“IVC”) procedure enabled by our INVOcell® medical device (“INVOcell”) and US-based, profitable in vitro fertilization (“IVF”) clinics. We have two operational INVO Centers in the United States and one IVF clinic. We also continue to engage in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments. We believe the IVC procedure can deliver comparable results at a fraction of the cost of traditional IVF and is a significantly more effective treatment than intrauterine insemination. For more information, please visit invofertility.com.
For more information, please contact:
INVO Fertility, Inc.
Steve Shum, CEO
978-878-9505
sshum@invofertility.com
Investor Contact
Lytham Partners, LLC
Robert Blum
602-889-9700
INVO@lythampartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.